This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Pharmacyclics, Inc.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Alexander Jacob McVey: Innovator in Pharmaceutical Formulations
Introduction
Alexander Jacob McVey is a notable inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for various diseases. His work is characterized by a focus on innovative formulations that can lead to improved therapeutic outcomes.
Latest Patents
McVey holds a patent for a Bruton's tyrosine kinase (Btk) inhibitor. The patent describes the compound 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, along with novel pharmaceutical formulations. This invention includes pharmaceutical compositions that utilize the Btk inhibitor and outlines methods for its use in treating autoimmune diseases, heteroimmune diseases, cancer, including lymphoma, and inflammatory conditions.
Career Highlights
McVey is currently associated with Pharmacyclics, Inc., where he continues to advance his research and development efforts. His work has been instrumental in the creation of effective treatments that address complex medical conditions.
Collaborations
Some of McVey's notable coworkers include Harisha Atluri and Pearl Shwe-Cho Tay. Their collaborative efforts contribute to the innovative environment at Pharmacyclics, Inc.
Conclusion
Alexander Jacob McVey is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact the treatment of various diseases significantly. His contributions to the field exemplify the importance of innovation in healthcare.